Search Page

1

Cite

Share

Synthesis of C6-Substituted Purine Nucleoside Analogues via Late-Stage Photoredox/Nickel Dual Catalytic Cross-Coupling.

Perkins JJ, Shurtleff VW, Johnson AM, El Marrouni A. Perkins JJ, et al. ACS Med Chem Lett. 2021 Mar 8;12(4):662-666. doi: 10.1021/acsmedchemlett.0c00673. eCollection 2021 Apr 8. ACS Med Chem Lett. 2021. PMID: 33859805 Free PMC article.

Cite

Share

2

Cite

Share

Access to Unnatural α-Amino Acids via Visible-Light-Mediated Decarboxylative Conjugate Addition to Dehydroalanine.

Shah AA, Kelly MJ 3rd, Perkins JJ. Shah AA, et al. Among authors: perkins jj. Org Lett. 2020 Mar 20;22(6):2196-2200. doi: 10.1021/acs.orglett.0c00371. Epub 2020 Feb 28. Org Lett. 2020. PMID: 32109071

Cite

Share

3

Cite

Share

A Structured Approach to Intentional Interprofessional Experiential Education at a Non-Academic Community Hospital.

Nwaesei AS, Jacob BC, Peasah SK, Perkins JJ, Hogan M. Nwaesei AS, et al. Among authors: perkins jj. Am J Pharm Educ. 2019 Nov;83(9):7365. doi: 10.5688/ajpe7365. Am J Pharm Educ. 2019. PMID: 31871358 Free PMC article.

Cite

Share

4

Cite

Share

Development of a sp²-sp³ Stille Cross-Coupling for Rapid Synthesis of HIV NNRTI Doravirine Analogues.

ElMarrouni A, Campbell M, Perkins JJ, Converso A. ElMarrouni A, et al. Among authors: perkins jj. Org Lett. 2017 Jun 16;19(12):3071-3074. doi: 10.1021/acs.orglett.7b01142. Epub 2017 Jun 7. Org Lett. 2017. PMID: 28589720

Cite

Share

5

Cite

Share

Discovery of selective glucocorticoid receptor modulator MK-5932.

Bungard CJ, Hartman GD, Manikowski JJ, Perkins JJ, Bai C, Brandish PE, Euler DH, Hershey JC, Schmidt A, Fang Y, Norcross RT, Rushmore TH, Thompson CD, Meissner RS. Bungard CJ, et al. Among authors: perkins jj. Bioorg Med Chem. 2011 Dec 15;19(24):7374-86. doi: 10.1016/j.bmc.2011.10.054. Epub 2011 Oct 24. Bioorg Med Chem. 2011. PMID: 22079253

Cite

Share

6

Cite

Share

Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States.

Yin W, Horblyuk R, Perkins JJ, Sison S, Smith G, Snider JT, Wu Y, Philipson TJ. Yin W, et al. Among authors: perkins jj. J Occup Environ Med. 2017 Feb;59(2):198-204. doi: 10.1097/JOM.0000000000000936. J Occup Environ Med. 2017. PMID: 28166126

Cite

Share

7

Cite

Share

Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.

McKay RR, Lin X, Perkins JJ, Heng DY, Simantov R, Choueiri TK. McKay RR, et al. Among authors: perkins jj. Eur Urol. 2014 Sep;66(3):502-9. doi: 10.1016/j.eururo.2014.02.040. Epub 2014 Feb 26. Eur Urol. 2014. PMID: 24613250 Free PMC article.

Cite

Share

8

Cite

Share

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Grünwald V, McKay RR, Krajewski KM, Kalanovic D, Lin X, Perkins JJ, Simantov R, Choueiri TK. Grünwald V, et al. Among authors: perkins jj. Eur Urol. 2015 May;67(5):952-8. doi: 10.1016/j.eururo.2014.12.036. Epub 2015 Jan 7. Eur Urol. 2015. PMID: 25577718 Free PMC article.

Cite

Share

9

Cite

Share

Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States.

Zanotti G, Hunger M, Perkins JJ, Horblyuk R, Martin M. Zanotti G, et al. Among authors: perkins jj. BMC Cancer. 2017 Jun 2;17(1):393. doi: 10.1186/s12885-017-3379-1. BMC Cancer. 2017. PMID: 28578656 Free PMC article.

Cite

Share

10

Cite

Share

Clinical and economic outcomes by first-line treatment among women with HR+/HER2- metastatic breast cancer in a large US health plan database.

Burton T, Byfield SD, Smith GL, Zanotti G, Bell TJ, Perkins JJ, Horblyuk R, Teitelbaum A. Burton T, et al. Among authors: perkins jj. Curr Med Res Opin. 2016 Aug;32(8):1417-23. doi: 10.1080/03007995.2016.1178108. Epub 2016 May 12. Curr Med Res Opin. 2016. PMID: 27074160

Cite

Share